Literature DB >> 7982914

Cloning and expression of the gene for group B streptococcal hyaluronate lyase.

B Lin1, S K Hollingshead, J E Coligan, M L Egan, J R Baker, D G Pritchard.   

Abstract

Group B streptococci (GBS) are a major cause of serious human perinatal infections. Most clinical isolates of GBS secrete hyaluronate lyase, and production of high levels of the enzyme has been associated with strain virulence. Degenerate oligonucleotide primers, designed on the basis of the amino acid sequences of tryptic peptides prepared from the purified enzyme, permitted the polymerase chain reaction amplification from GBS chromosomal DNA of a 363-base pair internal DNA fragment of the GBS hyaluronate lyase gene (hylB). This DNA fragment was used as a probe to screen a lambda phage library of GBS chromosomal DNA fragments. Sequence analysis of positive clones identified an open reading frame capable of coding for a 111-kDa protein. Since no single clone was found to contain the entire gene it was necessary to reconstruct the gene from two plasmids containing inserts with suitable overlapping sequences. When this reconstructed gene was transformed into Escherichia coli, high level expression of hyaluronate lyase activity was obtained.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis.

Authors:  K Rolland; C Marois; V Siquier; B Cattier; R Quentin
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.

Authors:  David G Pritchard; Shengli Dong; Marion C Kirk; Robert T Cartee; John R Baker
Journal:  Appl Environ Microbiol       Date:  2007-09-28       Impact factor: 4.792

Review 3.  Recent advances in understanding the molecular basis of group B Streptococcus virulence.

Authors:  Heather C Maisey; Kelly S Doran; Victor Nizet
Journal:  Expert Rev Mol Med       Date:  2008-09-22       Impact factor: 5.600

4.  Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.

Authors:  S K Hollingshead; R Becker; D E Briles
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Characterization of PepB, a group B streptococcal oligopeptidase.

Authors:  B Lin; W F Averett; J Novak; W W Chatham; S K Hollingshead; J E Coligan; M L Egan; D G Pritchard
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

6.  Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum.

Authors:  A L Tkalec; D Fink; F Blain; G Zhang-Sun; M Laliberte; D C Bennett; K Gu; J J Zimmermann; H Su
Journal:  Appl Environ Microbiol       Date:  2000-01       Impact factor: 4.792

7.  Hyaluronate lyase of a deep-sea Bacillus niacini.

Authors:  Atsushi Kurata; Mioko Matsumoto; Tohru Kobayashi; Shigeru Deguchi; Noriaki Kishimoto
Journal:  Mar Biotechnol (NY)       Date:  2015-02-14       Impact factor: 3.619

8.  Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates.

Authors:  Sharinne Sukhnanand; Belgin Dogan; Maranatha O Ayodele; Ruth N Zadoks; Mary Patricia J Craver; Nellie B Dumas; Ynte H Schukken; Kathryn J Boor; Martin Wiedmann
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease.

Authors:  M Hauge; C Jespersgaard; K Poulsen; M Kilian
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A.

Authors:  John R Baker; Shengli Dong; David G Pritchard
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.